NCT00645073

Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis

A Phase IV Comparative Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 271 (actual)
• Sponsor: Abbott · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To compare the safety and efficacy of a ten-day course of therapy of cefdinir, 600 mg QD, to a ten-day course of therapy of levofloxacin, 500 mg QD, in the treatment of acute bacterial sinusitis.

Conditions

• Acute Bacterial Sinusitis

Interventions

Type	Name	Description
DRUG	cefdinir (Omnicef)	Two 300 mg cefdinir capsules on Study Days 1-10.
DRUG	levofloxacin	Two 250 mg levofloxacin capsules on Study Days 1-10

Timeline

• Start date: 2003-11-01
• Primary completion: 2004-03-01
• First posted: 2008-03-27
• Last updated: 2008-03-27

Locations

33 sites across 2 countries: United States, Poland